Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
EPCLUSA
(https://epclusa.com) 📸 Data Snapshot: May 30, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option | Patient Site (https://epclusa.com)
EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option | Patient Site
Discover EPCLUSA® (sofosbuvir/velpatasvir), a prescription medicine used to treat chronic Hep C. See Important Safety Information including Important Warning.
NAV_HEADER_HEADING_REPEATED_FOOTER Why Treat Hep C Virus With EPCLUSA®? | Patient Site (https://epclusa.com/why-treat-hep-c/)
Why Treat Hep C Virus With EPCLUSA®? | Patient Site
Learn about the urgency & importance of treating your Hepatitis C. Read how to treat Hep C with EPCLUSA® & Important Safety Information, including Important Warning.
NAV_HEADER_HEADING_REPEATED_FOOTER Why Choose EPCLUSA® as Your Treatment for Hep C | Patient Site (https://epclusa.com/why-epclusa/)
Why Choose EPCLUSA® as Your Treatment for Hep C | Patient Site
EPCLUSA® (sofosbuvir/velpatasvir) may be a treatment choice for adults living with Chronic Hep C. Read Important Safety Information including Important Warning.
NAV_HEADER_HEADING_REPEATED_FOOTER EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg) Resources | Patient Site (https://epclusa.com/helpful-resources/)
EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg) Resources | Patient Site
Find downloadable resources to help you speak to a healthcare provider. Watch the EPCLUSA® (sofosbuvir/velpatasvir) Hep C commercial to learn more. Read Important Safety Information Including Important Warning.
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE · THIN (https://epclusa.com) EPCLUSA® (sofosbuvir/velpatasvir) A Hep C Treatment Option | Patient Site
SUB-PAGE · THIN (https://epclusa.com/why-treat-hep-c/) Why Treat Hep C Virus With EPCLUSA®? | Patient Site
SUB-PAGE · THIN (https://epclusa.com/why-epclusa/) Why Choose EPCLUSA® as Your Treatment for Hep C | Patient Site
SUB-PAGE · THIN (https://epclusa.com/helpful-resources/) EPCLUSA® (sofosbuvir 400 mg/velpatasvir 100 mg) Resources | Patient Site
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
| /why-treat-hep-c/ | 0 | 0 |
| /why-epclusa/ | 0 | 0 |
| /helpful-resources/ | 0 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 784 businesses audited.
EPCLUSA has 2.7 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: EPCLUSA (epclusa.com)
EPCLUSA provides a highly coherent, patient-focused narrative that is low on typical ‘corporate synergy’ BS but high on pharmaceutical gatekeeping. It successfully avoids semantic drift but fails technically on authority through a total absence of structured data and external evidence paths. It is a well-designed marketing tool that prioritizes convenience claims over clinical transparency.
Implement MedicalWebPage and Organization schema_json to establish technical authority and link to the parent company’s sameAs profiles. Replace redundant H6 ‘Find confidence’ tags with specific H2/H3 headings citing clinical trial cure rates (e.g., ‘98% Cure Rate in Clinical Trials’). Add a dedicated ‘Clinical Evidence’ section to the Why Epclusa page with direct outbound links to published peer-reviewed studies on PubMed. Ensure all H1 tags are populated with the specific drug name and primary indication to fix the broken heading hierarchy.
The content perfectly aligns with the Pharmaceutical and Biotech industry. It focuses on a specific therapeutic area (Hepatitis C), mentions specific drug components (sofosbuvir/velpatasvir), and adheres to regulatory-mandated safety information and indications for use.
“The score of 38 reflects a site that is medically substantial but technically weak in the Authority and Trust pillars. The Information Density and Semantic Coherence pillars performed exceptionally well, preventing a higher BS score. The lack of schema and external proof paths are the primary drivers of the final score.”
This training module utilizes a snapshot of public data from EPCLUSA, captured on May 30, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to EPCLUSA: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://epclusa.com to view the most current version of its content and learn from the source what this company is about and what it offers.